Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suprascapular Nerve Corticosteroid Injection vs Pulsed Radiofrequency in Chronic Shoulder Pain
2024-519892-24-00Phase 3Authorised
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Jan 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of triamcinolone acetonide in Chronic shoulder pain (2 arms), sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Primary endpoint: Shoulder Pain and Disability Index (SPADI). Planned start Jan 2025; status: authorised.
02
Drugs
triamcinolone acetonide
03
Conditions
Chronic shoulder pain
Beyond the preview
Go deeper on 2024-519892-24-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-519892-24-00.